163 related articles for article (PubMed ID: 24854489)
21. The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma.
Li L; Tao Q; Jin H; van Hasselt A; Poon FF; Wang X; Zeng MS; Jia WH; Zeng YX; Chan AT; Cao Y
Clin Cancer Res; 2010 Jun; 16(11):2949-58. PubMed ID: 20395212
[TBL] [Abstract][Full Text] [Related]
22. Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate.
Ezziddin S; Attassi M; Yong-Hing CJ; Ahmadzadehfar H; Willinek W; Grünwald F; Guhlke S; Biersack HJ; Sabet A
J Nucl Med; 2014 Feb; 55(2):183-90. PubMed ID: 24434296
[TBL] [Abstract][Full Text] [Related]
23. The diagnosis value of promoter methylation of UCHL1 in the serum for progression of gastric cancer.
Wang G; Zhang W; Zhou B; Jin C; Wang Z; Yang Y; Wang Z; Chen Y; Feng X
Biomed Res Int; 2015; 2015():741030. PubMed ID: 26550574
[TBL] [Abstract][Full Text] [Related]
24. High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event.
Knösel T; Chen Y; Altendorf-Hofmann A; Danielczok C; Freesmeyer M; Settmacher U; Wurst C; Schulz S; Yang LL; Petersen I
J Cancer Res Clin Oncol; 2012 Mar; 138(3):397-403. PubMed ID: 22160160
[TBL] [Abstract][Full Text] [Related]
25. Frequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulation.
Rahman MM; Qian ZR; Wang EL; Sultana R; Kudo E; Nakasono M; Hayashi T; Kakiuchi S; Sano T
Br J Cancer; 2009 Feb; 100(3):501-10. PubMed ID: 19156147
[TBL] [Abstract][Full Text] [Related]
26. Clinico-morphological analysis of the neuroendocrine neoplasms of the gastroenteropancreatic system.
Delektorskaya VV; Kozlov NA; Chemeris GY
Klin Lab Diagn; 2013 Oct; (10):48-50, 10-3. PubMed ID: 24640093
[TBL] [Abstract][Full Text] [Related]
27. The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors.
Figueroa-Vega N; Díaz A; Adrados M; Alvarez-Escolá C; Paniagua A; Aragonés J; Martín-Pérez E; Leskela S; Moreno-Otero R; González-Amaro R; Marazuela M
Endocr Relat Cancer; 2010 Dec; 17(4):897-908. PubMed ID: 20696814
[TBL] [Abstract][Full Text] [Related]
28. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneous expression and functional relevance of the ubiquitin carboxyl-terminal hydrolase L1 in melanoma.
Wulfänger J; Biehl K; Tetzner A; Wild P; Ikenberg K; Meyer S; Seliger B
Int J Cancer; 2013 Dec; 133(11):2522-32. PubMed ID: 23686552
[TBL] [Abstract][Full Text] [Related]
30. Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness.
Barrea L; Altieri B; Muscogiuri G; Laudisio D; Annunziata G; Colao A; Faggiano A; Savastano S
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513732
[TBL] [Abstract][Full Text] [Related]
31. The molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Zikusoka MN; Kidd M; Eick G; Latich I; Modlin IM
Cancer; 2005 Dec; 104(11):2292-309. PubMed ID: 16258976
[TBL] [Abstract][Full Text] [Related]
32. Silencing of the UCHL1 gene in human colorectal and ovarian cancers.
Okochi-Takada E; Nakazawa K; Wakabayashi M; Mori A; Ichimura S; Yasugi T; Ushijima T
Int J Cancer; 2006 Sep; 119(6):1338-44. PubMed ID: 16642472
[TBL] [Abstract][Full Text] [Related]
33. The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours.
Foltyn W; Zajęcki W; Marek B; Kajdaniuk D; Siemińska L; Zemczak A; Kos-Kudła B
Endokrynol Pol; 2012; 63(5):362-6. PubMed ID: 23115069
[TBL] [Abstract][Full Text] [Related]
34. The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs.
Kim ST; Ha SY; Lee S; Ahn S; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim KM; Park YS
J Cancer; 2016; 7(5):484-9. PubMed ID: 26958083
[TBL] [Abstract][Full Text] [Related]
35. Higher IL-6 peri-tumoural expression is associated with gastro-intestinal neuroendocrine tumour progression.
Pereira SS; Pereira R; Santos AP; Costa MM; Morais T; Sampaio P; Machado B; Afonso LP; Henrique R; Monteiro MP
Pathology; 2019 Oct; 51(6):593-599. PubMed ID: 31466863
[TBL] [Abstract][Full Text] [Related]
36. Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors.
Dhall D; Mertens R; Bresee C; Parakh R; Wang HL; Li M; Dhall G; Colquhoun SD; Ines D; Chung F; Yu R; Nissen NN; Wolin E
Hum Pathol; 2012 Apr; 43(4):489-95. PubMed ID: 21937080
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitin carboxyl-terminal esterase L1 (UCHL1) is associated with stem-like cancer cell functions in pediatric high-grade glioma.
Sanchez-Diaz PC; Chang JC; Moses ES; Dao T; Chen Y; Hung JY
PLoS One; 2017; 12(5):e0176879. PubMed ID: 28472177
[TBL] [Abstract][Full Text] [Related]
38. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK
Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
[TBL] [Abstract][Full Text] [Related]
39. APOBEC3B High Expression in Gastroenteropancreatic Neuroendocrine Neoplasms and Association With Lymph Metastasis.
Feng C; Zheng Q; Yang Y; Xu M; Lian Y; Huang J; Jiang Y
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):599-605. PubMed ID: 30095460
[TBL] [Abstract][Full Text] [Related]
40. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.
Klöppel G; Rindi G; Anlauf M; Perren A; Komminoth P
Virchows Arch; 2007 Aug; 451 Suppl 1():S9-27. PubMed ID: 17684761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
